MedTrace Logo

Safety and Efficacy of SRD441 Ointment in Patients With Atopic Dermatitis

NCT00882245 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2009-10-30

No results posted yet for this study

Summary

Atopic Dermatitis is a chronic inflammatory skin disease that affect 10 to 15% of children and 2 to 10% of adults. AD is characterised by an itchy skin eruption and may cover large parts of the body. The exact cause is unknown but is thought to be an interplay between genetic and and environmental factors. The objective of this study is to determine whether SRD441 ointment is a safe and effective therapy for mild to moderate Atopic Dermatitis.

Conditions

Interventions

OTHER

Vehicle ointment

Topical vehicle cream

DRUG

Ointment

SRD441 Ointment

Sponsors & Collaborators

  • Serentis Ltd.

    lead INDUSTRY

Principal Investigators

  • Robert Tansley · Serentis Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2009-08-31
Completion
2009-10-31

Countries

  • Bulgaria
  • Finland
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00882245 on ClinicalTrials.gov